The growing demand for specific immunological research and therapeutic design has spurred significant advances in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using multiple expression systems, including prokaryotic hosts, animal cell cultures, and viral rep